Detailed price information for Assembly Biosciences (ASMB-Q) from The Globe and Mail including charting and trades.

The topline data showed ISM001-055 to have improved the forced vital capacity (FVC) of IPF patients studied 12 weeks after ...

Prior to Gilead, she held leadership positions at Sana Biotechnology ... "I am passionate about innovation and technical ...

Developer Autolus set a list price of $525,000 for its new cell therapy, which it will sell for a type of leukemia under the ...

What is patent evergreening and what does the Indian patent regime tell us about it? Also, go beyond the nugget to know about ...

Healthcare sector earnings report summary: 14 companies beat profit estimates, with major players like Viatris, Gilead ...

Fintel reports that on November 8, 2024, Maxim Group downgraded their outlook for Gilead Sciences (NasdaqGS:GILD) from Buy to ...

How Life Began on Earth: Modeling Earth's Ancient Atmosphere Oct. 31, 2024 — This model reveals how vastly different the atmosphere was on ancient Earth, and how life may have first ...

About Gilead Sciences Gilead Sciences, Inc. is a biopharmaceutical company ... The company is committed to advancing ...

AstraZeneca and Amgen's drug could have a new use after positive Phase 3 study results. Elsewhere, Jazz set new plans for a ...

Headquartered in Foster City, California, Gilead Sciences, Inc. (GILD) is a prominent biopharmaceutical company with a market ...